AIMS: To determine how excessive daytime sleepiness (EDS) and impaired cognition contribute to health-related quality of life (HRQL) in heart failure (HF). METHODS AND RESULTS: Adults with chronic HF were enrolled into a prospective cohort study. Data were obtained from 280 subjects enrolled from three sites in the northeastern USA; 242 completed the 6-month study. At baseline, cohorts with and without EDS were identified using the Epworth Sleepiness Scale. Each EDS group was further subdivided into those with and without impaired cognition using a battery of five neuropsychological tests. Two disease-specific measures, the Kansas City Cardiomyopathy Questionnaire (KCCQ) and the Functional Outcomes of Sleep Questionnaire (FOSQ), were used to measure HRQL. General linear modelling of square-transformed variables was used to test the hypothesis that cohort membership was a significant predictor of HRQL. At 6 months the remaining sample was 62.5 [standard deviation (SD) 12] years old, mostly male (63%), white (65%), and functionally compromised [72% New York Heart Association (NYHA) class III/IV]. The cohort with both EDS and impaired cognition had the lowest KCCQ overall summary score (60.5 ± 22.5) compared with the cohort without EDS or impaired cognition (74.6 ± 17.4, P ≤ 0.001). A similar effect was seen on the FOSQ (16.0 ± 2.8 vs. 18.5 ± 2.2, P < 0.001). CONCLUSION: Impaired cognition alone did not explain poor HRQL, but the addition of EDS poses a significant risk for poor HRQL. Interventions designed to influence EDS may improve HRQL in this population.
AIMS: To determine how excessive daytime sleepiness (EDS) and impaired cognition contribute to health-related quality of life (HRQL) in heart failure (HF). METHODS AND RESULTS: Adults with chronic HF were enrolled into a prospective cohort study. Data were obtained from 280 subjects enrolled from three sites in the northeastern USA; 242 completed the 6-month study. At baseline, cohorts with and without EDS were identified using the Epworth Sleepiness Scale. Each EDS group was further subdivided into those with and without impaired cognition using a battery of five neuropsychological tests. Two disease-specific measures, the Kansas City Cardiomyopathy Questionnaire (KCCQ) and the Functional Outcomes of Sleep Questionnaire (FOSQ), were used to measure HRQL. General linear modelling of square-transformed variables was used to test the hypothesis that cohort membership was a significant predictor of HRQL. At 6 months the remaining sample was 62.5 [standard deviation (SD) 12] years old, mostly male (63%), white (65%), and functionally compromised [72% New York Heart Association (NYHA) class III/IV]. The cohort with both EDS and impaired cognition had the lowest KCCQ overall summary score (60.5 ± 22.5) compared with the cohort without EDS or impaired cognition (74.6 ± 17.4, P ≤ 0.001). A similar effect was seen on the FOSQ (16.0 ± 2.8 vs. 18.5 ± 2.2, P < 0.001). CONCLUSION:Impaired cognition alone did not explain poor HRQL, but the addition of EDS poses a significant risk for poor HRQL. Interventions designed to influence EDS may improve HRQL in this population.
Authors: Susan J Pressler; Barbara Therrien; Penny L Riley; Cheng-Chen Chou; David L Ronis; Todd M Koelling; Dean G Smith; Barbara Jean Sullivan; Ann-Marie Frankini; Bruno Giordani Journal: J Card Fail Date: 2011-10 Impact factor: 5.712
Authors: Alison M Mudge; Charles P Denaro; Adam C Scott; John J Atherton; Deborah E Meyers; Thomas H Marwick; Julie A Adsett; Robert W Mullins; Jessica M Suna; Paul A Scuffham; Peter K O'Rourke Journal: Eur J Heart Fail Date: 2011-11-06 Impact factor: 15.534
Authors: Barbara Riegel; Alexandra L Hanlon; Xuemei Zhang; Desiree Fleck; Steven L Sayers; Lee R Goldberg; William S Weintraub Journal: J Am Assoc Nurse Pract Date: 2012-09-24 Impact factor: 1.165
Authors: Barbara Riegel; Stephen T Moelter; Sarah J Ratcliffe; Susan J Pressler; Sabina De Geest; Sheryl Potashnik; Desiree Fleck; Daohang Sha; Steven L Sayers; William S Weintraub; Terri E Weaver; Lee R Goldberg Journal: J Card Fail Date: 2010-12-24 Impact factor: 5.712
Authors: Susan J Pressler; Usha Subramanian; David Kareken; Susan M Perkins; Irmina Gradus-Pizlo; Mary Jane Sauvé; Yan Ding; JinShil Kim; Rebecca Sloan; Heather Jaynes; Rose M Shaw Journal: J Cardiovasc Nurs Date: 2010 May-Jun Impact factor: 2.083
Authors: K Mulligan; P A Mehta; T Fteropoulli; S W Dubrey; H F McIntyre; T A McDonagh; G C Sutton; D M Walker; M R Cowie; S Newman Journal: Br J Health Psychol Date: 2011-08-25
Authors: Christopher S Lee; Jill M Gelow; Christopher V Chien; Shirin O Hiatt; Julie T Bidwell; Quin E Denfeld; Kathleen L Grady; James O Mudd Journal: J Cardiovasc Nurs Date: 2018 Mar/Apr Impact factor: 2.083
Authors: Debra K Moser; Cynthia Arslanian-Engoren; Martha J Biddle; Misook Lee Chung; Rebecca L Dekker; Muna H Hammash; Gia Mudd-Martin; Abdullah S Alhurani; Terry A Lennie Journal: Curr Cardiol Rep Date: 2016-12 Impact factor: 2.931